MVision AI

Koti
Suomi
Helsinki
MVision AI

Yhteystiedot, kartta ja reittiohjeet, yhteydenottolomake, aukioloajat, palvelut, arvostelut, kuvat, videot ja ilmoitukset MVision AI, Terveys, PaciuksenKatu 29, Helsinki :ltä.

MVision develops AI-powered solutions that automate repetitive tasks, enable efficient radiotherapy workflows, and promote consistency across clinical processes.

10/12/2025

Recently, MVision AI Founder and CEO Mahmudul Hasan and Radiation Oncologist Norina Predescu attended the BICC 2025 conference in Bangladesh. Their visit included hospital meetings, discussions with clinicians, and participation in sessions focused on the future of cancer care.

Together, they have shared their reflections on the experience. The piece offers an honest look at the challenges radiotherapy teams in Bangladesh face. Just as importantly, it highlights the determination, curiosity, and willingness among clinicians to explore how AI can support daily practice and strengthen patient care.

Their story illustrates how progress takes shape when on-the-ground experience comes together with solutions designed around real clinical challenges.

Read the full article here: https://bit.ly/3XNEyBL

06/12/2025

Finnish Independence Day reminds us of the values that stand at the heart of this country: steadiness, resilience, and a forward-looking mindset.

They underpin the way we at MVision AI work to support improvements in cancer care.

Happy and peaceful Independence Day, Finland! Hyvää itsenäisyyspäivää!

05/12/2025

Congratulations to the Bath Cancer Unit Support Group for receiving a grant from The Richard Oatley Foundation to fund years 3 and 4 of using MVision Contour+, Guide and Verify at the Royal United Hospital, Bath. Together with our partner Xiel, we are proud to play a role in a project that strengthens radiotherapy services for the local community.

BCUSG has supported the cancer unit since 1979. Their fundraising continues to play a valuable role in bringing new equipment and improved facilities to the hospital. Their commitment also helps make advanced tools available to clinicians at the RUH. The Richard Oatley Foundation has again shown meaningful support for local healthcare, continuing its earlier funding and recognising the remarkable contribution raised by surgeon Stuart Gillett.

We applaud the efforts of BCUSG and the positive impact they have on both oncology professionals and the patients receiving care.

Learn more about the initiative at https://bit.ly/48TPGmL

04/12/2025

Adapt+ enables automated contour propagation to support adaptive radiotherapy preparation. It aligns planning contours to new scans using clinically evaluated image registration methods and supports consistent results for clinicians to review.

Watch the video below and learn more at https://bit.ly/4owx4Oc

*This product is not available in all markets.

01/12/2025

JASTRO 2025 has come to a close, and we’re grateful for an inspiring few days in Tokyo.

It was a pleasure to connect with clinicians, researchers, and many others who are shaping the future of radiation oncology in Japan and beyond. The discussions around innovation, collaboration, and the evolving role of technology in cancer care were truly encouraging.

Thank you to everyone who visited us at Booth K5, shared their perspectives, or engaged in conversations about advancing radiotherapy. We appreciate the interest, the questions, and the thoughtful exchanges that drive progress forward.

We look forward to continuing these conversations and to meeting again next year at .

27/11/2025

You’ve probably heard about our latest innovation, Workspace+ — our unified AI platform for radiotherapy planning preparation.

The video below gives a quick introduction to the platform and its core capabilities: contouring, synthetic CT generation, dose prediction, and adaptive tools using registration and contour propagation.

Learn more or book a demo at https://eu1.hubs.ly/H0p_Nss0

*CE-marked (CE 2797) medical device under EU MDR 2017/745; this product is not available in all markets.

25/11/2025

MVision AI will attend the 38th Annual Meeting of the Japanese Society for Radiation Oncology (JASTRO 2025) from November 27–29 at the Tokyo International Forum.

This year’s theme, “IMAGINE THE FUTURE – Let's Talk about the Future of Cancer Treatment,” calls for forward-looking discussions on how technology and collaboration can shape the next era of radiotherapy.

We will be at Booth K5 with our distributor Item Corporation to showcase and discuss our products.

We look forward to meaningful conversations on the future of cancer treatment and to connecting with clinicians, researchers, and partners driving progress in radiotherapy.

*Technologies featured are not yet regulatory approved and currently not available for sale in Japan. Please contact our team at info@mvision.ai or our distributor at ft.maeda@item-corp.jp for more information.

24/11/2025

The Saudi Association of Radiation Therapy (SART) is hosting the second session of its virtual lecture series, featuring insights from MVision AI on how automation can support smoother radiotherapy workflows and more effective treatment delivery.

MVision AI Customer Success Manager Rachel Buckingham and Customer Success Specialist Hassan Mohamed Hassan will discuss practical approaches to integrating AI-driven tools in clinical practice. The event will be moderated by Shaikh Aakif Masood.

Date: 26 November 2025
Time: 4:00–5:00 PM (Europe/London time)
Join here: https://eu1.hubs.ly/H0pWDxC0

A great opportunity for anyone interested in advancing radiotherapy practice. Hope to see you there.

20/11/2025

Together with our partner S.L.T. Srl, we will join the AIRO 2025 National Congress in Rimini, Italy, from November 21 to 23, 2025. This year’s meeting highlights innovation, collaboration, and the future of personalized cancer treatment, themes that reflect our commitment to advancing precision and quality in radiotherapy.

At Booth FP15, we will be ready to discuss our portfolio of AI-powered solutions designed to support accuracy, consistency, and efficiency across radiotherapy workflows.

We are particularly excited to talk about Workspace+, our newest intelligent AI platform that brings contouring, synthetic imaging, dose prediction, and contour propagation together in one secure environment. It helps clinical teams automate preparation workflows while maintaining oversight and confidence in every step.

We look forward to connecting with the radiation oncology community in Rimini and exploring how AI can continue to enhance the performance of radiotherapy.

*Workspace+ is a CE-marked (CE 2797) medical device under EU MDR 2017/745; it is not available in all markets.

Osoite

PaciuksenKatu 29
Helsinki
00270

Nettisivu

http://www.mvision.ai/

Hälytykset

Tiedä ensimmäisenä ja anna meille oikeus lähettää sinulle sähköpostitse uutisia ja promootioita MVision AI :ltä. Sähköpostiosoitettasi ei käytetä muihin tarkoituksiin, ja voit perua milloin tahansa.

Oma vastaanotto listan huipulle Klinikka Helsinki :ssa?

Jaa

Kategoria

Terveys